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The	human	intestinal	B-cell	response	
Abstract	The	intestinal	immune	system	is	chronically	challenged	by	a	huge	plethora	of	antigens	derived	from	the	lumen.	B-cell	responses	in	organised	gut-associated	lymphoid	tissues	(GALT)	and	regional	lymph	nodes	that	are	driven	chronically	by	gut	antigens	generate	the	largest	population	of	antibody	producing	cells	in	the	body;	the	gut	lamina	propria	plasma	cells.	Although	animal	studies	have	provided	insights	into	mechanisms	that	underpin	this	dynamic	process,	some	very	fundamental	differences	in	this	system	appear	to	exist	between	species.	Importantly,	this	prevents	extrapolation	from	mice	to	humans	to	inform	translational	research	questions.	Therefore,	in	this	review	we	will	describe	the	structures	and	mechanisms	involved	in	the	propagation,	dissemination	and	regulation	of	this	immense	plasma	cell	population	in	man.	Uniquely,	we	will	seek	our	evidence	exclusively	from	studies	of	human	cells	and	tissues.		
Introduction	Immune	protection	of	the	human	intestinal	mucosa	depends	on	the	secretion	of	IgA	by	plasma	cells	that	occupy	the	diffuse	subepithelial	connective	tissue	of	the	intestinal	lamina	propria.	Locally	secreted	IgA	bound	to	polymeric	immunoglobulin	receptor	(pIgR)	is	actively	transported	into	the	gut	lumen	where	it	regulates	bacterial	populations.1,	2	The	body	commits	considerable	resources	to	the	production	of	intestinal	IgA.	The	number	of	IgA	producing	plasma	cells,	at	approximately	6x1010,	exceeds	the	total	number	of	plasma	cells	in	the	rest	of	the	body	combined,	including	bone	marrow,	lymph	nodes	and	spleen.1,	3	Intestinal	plasma	cells	secrete	between	3	and	5g	of	IgA	per	day	that	is	actively	transported	into	the	gut	lumen	to	provide	continuous	protection	of	the	mucosal	barrier.	Human	intestinal	IgA	is	mostly	dimeric	and	comprises	both	the	IgA1	and	IgA2	subclass.	The	ratio	between	plasma	cells	secreting	the	two	subclasses	of	IgA	is	not	the	same	through	the	gastrointestinal	tract.	Whereas	most	plasma	
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cells	in	the	small	intestine	secrete	IgA1,	the	proportion	of	IgA2	increases	from	the	duodenum	through	to	the	terminal	ileum	and	the	subclasses	are	present	in	approximately	equal	numbers	in	the	colon	(Figure	1).	IgA2	has	a	shorter	hinge	than	IgA1	and	as	a	consequence	is	less	susceptible	to	bacterial	proteases	and	would	therefore	have	a	functional	advantage	in	the	lumen	of	the	colon	that	is	rich	in	bacterial	species.	In	contrast,	whilst	IgA	is	the	second	most	common	immunoglobulin	isotype	in	blood	after	IgG,	most	IgA	in	serum	is	monomeric	IgA1	(ref	1).		The	precursors	of	lamina	propria	IgA	plasma	cells	are	generated	in	microanatomically	discrete	zones	of	organised	lymphoid	inductive	sites	such	as	the	gut-associated	lymphoid	tissue	(GALT)	and	gut	regional	lymph	nodes	(Figure	1).	First	we	will	consider	the	structure	and	function	of	human	GALT	and	then	the	derivation	and	unique	properties	of	intestinal	plasma	cells	themselves.		
B	cells	in	gut-associated	lymphoid	tissue	Most	of	the	intestine	is	structured	to	prevent	the	entry	of	potentially	pathogenic	material	into	the	body,	for	example	by	epithelial	tight	junctions	to	maintain	the	integrity	of	the	monolayer	even	through	rapid	cell	turnover	and	the	production	of	anti-microbial	peptides	such	as	defensins.4,	5	In	contrast,	GALT	is	associated	with	an	epithelial	structure	that	facilitates	antigen	entry	(Figure	1).	Antigens	may	be	sampled	by	epithelial	cells	termed	microfold	(M)	cells	that	comprise	part	of	the	specialised	follicle	associated	epithelium	(FAE).6	GALT	covered	by	an	FAE	may	be	located	anywhere	through	the	GI	tract	but	tends	to	be	concentrated	in	the	terminal	ileum	and	the	appendix.7	In	these	locations	GALT	comprises	lymphoid	follicles	that	tend	to	be	located	on	the	mucosal	aspect	of	the	muscularis	mucosae	with	a	broad	and	relatively	exposed	FAE	8.	In	colon	most	of	the	lymphoid	tissue	tends	to	be	concentrated	on	the	
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serosal	side	of	the	muscularis	layer,	protruding	through	a	hole	in	the	muscularis	and	forming	a	narrow	FAE	interface	with	the	lumen.9				The	FAE	interacts	intimately	with	the	lymphoid	tissue	below	and	is	infiltrated	by	lymphocytes,	including	B	cells,	from	approximately	20	weeks	of	gestation	onwards.10,	11	The	amount	of	lymphoid	tissue	present	in	the	gut	increases	through	the	last	20	weeks	of	gestation,	with	acquisition	accelerating	after	birth	and	continuing	to	increase	through	to	12	years	of	age,	after	which	the	number	of	lymphoid	follicles	declines	so	that	their	frequency	reaches	levels	present	at	birth	in	the	8th	decade.12		Gut-associated	lymphoid	tissue	contains	diverse	B-cell	subsets.		The	central	feature	of	most	GALT	in	the	small	intestine	and	appendix	are	the	prominent	germinal	centers	(GC)	containing	B	cells	that	have	been	activated.	B	cells	in	GC	are	surrounded	by	other	cells	such	as	follicle	dendritic	cells,	T	follicular	helper	cells	and	tingible	body	macrophages	that	support	GC	B-cell	clonal	expansion	and	selection	(Figure	2).	The	ubiquitous	presence	of	a	GC	in	small	intestinal	GALT	is	likely	a	reflection	of	the	chronic	stimulation	by	antigens	derived	from	the	lumen	via	the	FAE	and	the	high	antigen	load.	Pockets	of	cells	that	have	features	of	GC	B	cells	have	been	described	in	FAE13	suggesting	unique	features	of	B-cell	responses	with	FAE	location.	Colonic	GALT	less	consistently	contains	a	GC	though	the	likelihood	of	the	presence	of	GC	in	colonic	GALT	is	increased	by	the	presence	of	a	colonic	tumor.9		The	GC	is	surrounded	by	a	mantle	zone	of	CD27-IgM+IgD+	mature	naïve	B	cells	that	is	generally	sparse	in	GALT	compared	to	the	tonsil	or	a	lymph	node.	The	mantle	has	its	broadest	aspect	facing	the	direction	of	antigen	entry;	either	the	FAE	of	GALT	or	the	subcapsular	sinus	of	lymph	node.	The	mantle	zone	of	GALT	is	surrounded	by	a	marginal	zone	of	B	cells	that	lack	the	strong	expression	of	IgD	of	mantle	zone	cells,	and	that	extends	to	and	infiltrates	the	
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adjacent	FAE.11	The	GALT	marginal	zone	B	cells	are	considered	to	be	the	benign	analogue	of	the	malignant	B	cells	in	marginal	zone	B-cell	lymphoma	of	MALT	(MALT	lymphoma).14	Normal	FAE	retains	a	tight	structure	despite	mild	disruption	by	infiltrating	lymphocytes.		In	contrast,	the	lymphoepithelium	formed	by	MALT	lymphoma	is	a	destructive	lesion	that	is	pathognomonic	of	the	tumor.14						
B	cells	outside	gut-associated	lymphoid	tissue	in	the	lamina	propria		Whereas	CD20+	B	cells	are	numerous	in	GALT	structures,	they	are	scarce	in	the	lamina	propria	(Figure	3).	A	few	scattered	B	cells	(CD20+,	CD27+,	MHCII+),	mainly	IgA	expressing,	can	be	observed	in	sections	of	jejunal	tissue.	This	is	in	contrast	to	what	is	observed	by	flow	cytometry	analysis	of	single	cell	suspension	made	from	resection	specimens.	In	this	case,	numerous	B	cells	including	sIgD+	naïve	B	cells,	can	be	observed.	Thus	contamination	of	cells	from	GALT	structures	is	an	important	confounder	in	analysis	of	single	cell	suspension	of	mucosal	tissue	samples.	B	lineage	effector	cells	secreting	antibodies,	i.e.	plasma	cells	and	plasmablasts,	have	an	almost	exclusive	distribution	in	the	gut	in	the	lamina	propria.15	IgA	is	by	far	the	dominant	isotype	produced	by	these	cells.	In	duodenum/jejunum,	79%	of	plasma	cells	express	IgA,	18%	express	IgM	and	3%	express	IgG,	whereas	the	corresponding	numbers	in	colon	are	90%,	6%	and	4%.1	In	the	small	intestine	most	of	the	plasma	cells	are	localized	in	a	zone	stretching	from	the	luminal	100	µm	of	the	crypt	layer	to	the	basal	100	µm	of	the	villi,	a	zone	intermingled	with	a	few	T	cells.1	Initial	observations	by	Farstad	et	al	reported	that	some	IgA	immunocytes	express	surface	immunoglobulin	and	it	was	suggested	that	these	antibody-secreting	cells	represent	recently	arrived	plasmablasts.15	Benkert	et	al	also	termed	these	cells	plasmablasts	as	the	authors	found,	similar	to	what	had	been	observed	by	Di	Niro	et	al,	that	virtually	all	gut	IgA	and	IgM	ASC	express	surface	immunoglobulin.16,	17	Notwithstanding,	these	cells	generally	lack	intracellular	expression	of	proliferation-associated	protein	Ki-67	and	express	CD138	indicating	that	they	are	plasma	cells	rather	than	plasmablasts.17	Further	in	
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support	of	the	notion	that	these	are	not	plasmablasts	captured	in	narrow	window	of	differentiation,	it	was	observed	that	surface	immunoglobulin	is	maintained	on	antibody-secreting	cells	in	culture	of	gut	biopsies	even	after	4	weeks.18	The	expression	of	surface	IgA	and	IgM	is	not	unique	to	gut	antibody	secreting	cells	as	this	feature	is	also	observed	in	plasma	cells	of	the	bone	marrow.19	In	fact,	the	surface	immunoglobulin	of	IgA	and	IgM	plasma	cells	appears	to	be	a	functional	B-cell	receptor	that	is	associated	with	Iga/Igb.		Consistent	with	this,	cross-linking	of	IgA	and	IgM	on	the	surface	of	plasma	cells	gives	Ca2+	mobilization	and	extracellular	signal-regulated	kinase	1/2	and	AKT	phosphorylation.	B-cell	receptor	cross-linking	furthermore	leads	to	increased	survival	of	IgA	plasma	cells	as	measured	by	intact	immunoglobulin	secretion	after	4	days.19	In	contrast	to	IgG	plasma	cells	that	are	located	at	sites		(bone	marrow	and	spleen)	mostly	devoid	of	antigen,	IgA	and	IgM	plasma	cells	are	primarily	located	at	mucosal	sites	where	they	can	be	in	contact	with	antigen.	Thus,	sensing	of	antigen	by	IgA	and	IgM	plasma	cells	using	their	surface	antigen	receptor	could	help	guiding	production	of	secretory	immunoglobulin	for	which	there	is	a	need	both	by	stimulating	antibody	production	and	by	securing	cell	survival.	Plasma	cell		survival	could	either	happen	directly	as	indicated	by	Pinto	et	al	or	indirectly	via	T	cells	due	to	antigen	presentation	(Figure	4).	As	to	the	latter,	plasma	cells	have	barely	detectable	MHC	class	II	expression.	Notwithstanding,	if	the	few	MHC	class	II	molecules	are	loaded	with	peptides	from	antigen	extremely	efficiently	taken	up	by	the	cell	via	the	B-cell	receptor	this	could	be	sufficient	to	receive	T-cell	help.	The	two	mechanisms	are	not	mutually	exclusive,	and	further	work	is	needed	to	determine	whether	these	mechanisms	operate	in	the	gut.					High	dimension	analysis	of	B	cells	in	the	intestine	by	single-cell	mass	cytometry	demonstrated	that	intestinal	antibody	secreting	cells	generally	have	low	expression	of	chemokine	receptors	C-C	motif	receptor	6	(CCR6)	and	CCR7	and	high	expression	of	CCR10	and	CXCR4,	i.e.	they	carry	the	phenotype	CCR6lo/-CCR7lo/-CCR10+	CXCR4+	(ref		20).	The	expression	of	the	adhesion	
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molecule	a4b7	integrin	in	intestinal	antibody	secreting	cells	is	lower	than	of	antibody	secreting	cells	in	blood.	Further,	intestinal	and	circulating	antibody	secreting	cells	express	lower	levels	of	surface	IgA	and	CD40	than	switched	memory	B	cells,	and	interestingly,	in	contrast	to	circulating	antibody	secreting	cells	that	are	HLA-DR+/-CD95+,	intestinal	plasma	cells	are	generally	HLA-DR-CD95-.	This	suggests	that	the	cells	would	be	non-responsive	to	apoptosis	via	CD95	ligation.20		
Function	of	human	gut-associated	lymphoid	tissue	Precursors	of	human	IgA	plasma	cells	originate	from	the	GC	of	GALT.	Examples	of	clones	of	B	lineage	cells	(where	clones	are	identified	by	the	homology	of	junctional	sequences	of	their	rearranged	IGHV	genes)	that	are	present	in	both	the	GC	of	GALT	and	also	in	the	lamina	propria	plasma	cell	population	have	been	identified.21	Probably	the	best	evidence	for	involvement	of	the	GC	in	the	history	of	plasma	cells	in	health	is	the	very	high	frequency	of	somatic	mutations	in	the	rearranged	IGHV	genes	of	virtually	all	human	lamina	propria	plasma	cells	in	health.22	The	GC	is	the	only	place	known	where	somatic	mutations	are	introduced	with	high	frequency	into	IGV	genes.	The	AID	enzyme	that	catalyses	the	mutation	of	IGV	gene	segments	to	generate	variable	region	variants	is	expressed	in	the	nuclei	of	centroblasts	in	GALT	GCs	and	also	in	the	cytoplasm	of	relatively	sparse	large	interfollicular	B	cells,	the	significance	of	which	is	not	known.23,	24	The	reason	that	a	high	frequency	of	somatic	mutation	is	acquired	and	tolerated	such	that	on	average	approximately	8%	of	the	variable	region	sequence	is	changed,	despite	selective	pressure	to	maintain	structural	viability,	is	not	known.	It	may	be	a	consequence	of	drive	from	the	high	antigenic	load,	the	chronicity	of	the	challenge,	or	lower	selective	pressure	so	that	a	greater	range	of	variants	is	tolerated.		Despite	the	apparent	ubiquitous	involvement	of	GCs	in	GALT	plasma	cell	development,	it	is	likely	that	both	T-cell	independent	type	2	antigens	(TI2)	that	are	not	conventionally	
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associated	with	initiation	of	GC	responses	and	T-cell	dependent	antigens	can	both	drive	B-cell	activation	in	GALT.		The	gut	is	rich	in	bacterial	polysaccharide	antigens	with	repeating	subunit	structures	that	could	potentially	initiate	TI2	responses.25				One	of	the	most	distinctive	and	often	unappreciated	features	of	human	GALT	marginal	zone	B	cells	is	their	expression	of	Fc	receptor-like	4	(FCRL4,	previously	IRTA1	or	FCRH4)26	that	was	originally	identified	by	the	translocation	of	the	encoding	gene	to	the	Ig	locus	in	MALT	lymphoma.27	This	receptor,	that	does	not	occur	in	mice,	has	ITIM	motifs	and	dampens	polyclonal	immune	responses,	for	example	to	B	cell	receptor	signalling	or	Staphylococcus	aureus	Cowan	strain.		This	suggests	that	the	B	cells	on	the	mucosal	front	line	in	humans	have	distinctive	raised	thresholds	of	responsiveness.28,	29	It	has	also	been	demonstrated	that	FCRL4	may	detach	B	cell	responses	from	the	activation	signals	normally	driven	through	BCR	ligation	in	favour	of	responses	through	innate	receptors.30	In	health	FCRL4	expressing	B	cells	are	rare	in	blood	and	lymphoid	tissues	distant	from	epithelia.		However	they	accumulate	systemically	in	HIV	and	in	individuals	from	malaria	endemic	zones.31,	32	When	systemic	B	cells	express	FCRL4,	this	B	cell	subset	is	also	refractory	to	stimulation	and	has	been	described	as	‘exhausted’.	The	FCLR4	expressing	populations	in	blood	in	HIV	and	malaria	tend	to	be	CD27-.31,	32	Interestingly,	FCRL4+	cells	with	proinflammatory	properties	are	present	in	rheumatoid	synovium	suggesting	functional	similarity	between	B	cells	in	the	gut	and	the	rheumatoid	joint.	This	FCRL4+	population	is	predominantly	IgD-	and	includes	CD27+	and	CD27-	memory	subsets.33		The	induction	of	GCs	conventionally	requires	cognate	interaction	between	B	cells	and	T	cells	involving	the	ligation	of	CD40	on	B	cells	by	CD40L	on	peptide	primed	T	cells.		The	failure	of	this	in	X-linked	hyper	IgM	type	1	due	to	mutations	in	CD40L	results	in	deficiency	in	GC	formation	and	dearth	of	class	switched	B	cells	systemically.	Class	switch	to	IgA	can	however	
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be	retained	despite	CD40L	deficiency.34	Studies	of	blood	from	patients	with	CD40L	deficiency	have	identified	that	CD27-IgA+	B	cells	derived	in	the	absence	of	cognate	T	cell	help	that	are	present	in	similar	frequency	to	healthy	controls,	consistent	with	a	T-cell	independent	pathway	for	generation	of	IgA	expressing	memory	cells.34	CD27-	class	switched	memory	B	cells	are	also	increased	in	relative	frequency	in	patients	depleted	of	T	cells	by	HIV.35	Circulating	CD27-,	IgA+	B	cells	in	health	have	a	bias	towards	lambda	light	chain	usage,	a	relatively	low	frequency	of	somatic	mutations	and	relatively	more	polyreactive	immunoglobulins	with	a	greater	tendency	to	bind	bacterial	species	than	CD27+IgA+	cells.		They	also	have	a	gene	expression	profile	suggesting	ability	to	traffic	to	intestinal	sites.34,	36	Several	lines	of	evidence	described	above	tie	a	phenotype	of	CD27-	memory	B	cells	with	circumstances	of	B	cell	priming	in	the	absence	of	cognate	T-cell	help.		Whilst	phenotypic	profiles	particularly	involving	CD27	have	been	proposed	to	discriminate	between	B	cells	differentiating	along	T-cell	dependent	and	independent	pathways,	others	have	observed	that	memory	B	cell	clones	commonly	have	both	CD27+	and	CD27-	members.37	This	will	be	an	interesting	area	to	observe	in	the	future.				
IgA	class	switch	recombination	The	presence	of	IgA	in	patients	with	hyper	IgM	syndromes	suggests	that	class	switch	recombination	(CSR)	to	IgA	can	be	independent	of	cognate	B-cell	T-cell	interactions,34,	38	though	such	patients	often	have	small	residual	GC	structures	that	could	potentially	support	classically	GC	dependent	processes.39				Class	switch	to	IgA	requires	cell	proliferation,	induction	of	the	enzymes	that	mediate	the	recombination	process	such	as	AID	and	also	switch	factors	that	initiate	the	production	of	transcripts	from	the	noncoding	switch	regions	upstream	of	the	Iga1	and	Iga2	constant	region	segments	(Figure	5).		Double	strand	breaks	in	the	switch	regions	initiated	by	the	deamination	
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of	cytidine	in	the	repeating	motifs	that	guide	the	activity	of	AID	facilitate	the	exchange	of	constant	region	segments	in	dividing	cells.	Crosslinking	CD40	is	a	potent	stimulator	of	cell	division	that	can	also	activate	NFkB	resulting	in	upregulation	of	AID	to	mediate	CSR	to	all	isotypes	in	the	presence	of	appropriate	switch	factors.40	It	has	been	demonstrated	that	ligation	of	TACI	(transmembrane	activator	and	calcium	modulator	and	cyclophilin	ligand	interactor)	by	APRIL	(a	proliferation	inducing	ligand)	can	also	activate	NFKB	and	induce	AID	by	recruitment	of	MyD88	to	a	cytoplasmic	domain	of	TACI.41,	42	It	is	also	possible	that	innate	ligands	such	as	CpG	may	drive	cell	division	and	CSR	in	memory	cells	in	the	absence	of	cognate	interaction	with	T	cells.25		The	first	switch	factor	observed	to	induce	IgA	CSR	through	the	induction	of	transcription	of	Iga	switch	regions	was	TGFb.43	Other	cytokines	including	IL10	and	IL4	and	retinoic	acid	have	also	been	implicated	in	supporting	CSR	or	the	maturation	of	switched	B	cells.44,	45	Most	recently	IgA	inducing	protein	(IGIP)	produced	by	dendritic	cells,	that	have	previously	been	implicated	in	the	induction	of	IgA	CSR,38,	46	has	been	demonstrated	to	induce	IgA	switching.47	The	production	of	IGIP	by	dendritic	cells	is	regulated	by	vasoactive	peptide	(VIP).47				It	is	currently	unclear	how	preferential	switching	to	either	IgA1	or	IgA2	along	the	intestine	is	initiated.		Recombination	to	each	is	usually	direct.	Despite	its	downstream	location	to	IgA1,	switch	to	IgA2	is	unlikely	to	be	a	second	step	following	an	intermediate	switch	to	IgA1	(ref	48).		Interestingly	higher	frequencies	of	IgA2	secreting	cells	are	observed	in	locations	of	high	bacterial	load,	suggesting	that	preferential	switch	to	IgA2	may	be	a	feature	of	the	inducing	antigen.1,	49				During	the	first	month	of	life	IgA	secreting	plasma	cells	are	virtually	absent	from	the	intestinal	lamina	propria.		Their	subsequent	presence	increases	over	the	first	two	years	of	life	
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simultaneous	with	the	expression	of	APRIL	and	expression	of	its	receptors	TACI	and	BCMA	(B-cell	maturation	antigen)	in	GALT.	The	association	between	IgA	plasma	cell	appearance	and	the	presence	of	APRIL	and	its	receptors	suggests	that	this	axis	is	important	in	plasma	cell	development	in	early	life.24	Epithelial	APRIL	expression	may	be	modulated	by	the	ligation	of	TLR5	by	flagellin,	suggesting	that	the	microbiome	could	also	promote	IgA	CSR	indirectly.41		
Function	of	secretory	antibodies		The	plasma	cells	of	the	gut	express	the	J-chain	regardless	of	the	isotype	produced.50	The	J-chain	is	instrumental	to	make	dimeric	IgA	and	pentameric	IgM,	and	it	does	so	by	forming	covalent	disulphide	bridges	with	the	C-terminal	parts	of	the	a	and	µ	heavy	chains.51-53	Polymeric	IgA	and	IgM	by	means	of	their	J-chain	association	with	pIgR	expressed	on	the	basolateral	side	of	enterocytes54,	55	This	receptor	mediates	immunoglobulin	transport	across	the	epithelium.	Secretory	antibodies	are	released	by	cleavage	of	the	pIgR	at	the	luminal	membrane.		In	the	lumen	the	released	antibodies	can	bind	antigens	including	gut	microbes,2	and	thereby	mediate	immune	exclusion	and	antigen	clearance.	56	Of	note,	the	pIgR	can	also	transport	preformed	immune	complexes57	and	intracellular	dimeric	IgA	can	bind	and	neutralize	lipopolysaccharide	thereby	playing	an	anti-inflammatory	role.58				The	pIgR	is	not	the	only	receptor	for	IgA	on	enterocytes.	The	transferrin	receptor	(CD71)	does	also	bind	IgA1.59	The	transferrin	receptor	is	primarily	expressed	on	the	apical	side	of	enterocytes,	and	it	can	bind	and	mediate	retrotranscytosis	of	secretory	IgA.60	This	could	be	a	way	to	facilitate	uptake	of	antigens	across	the	epithelial	barrier	to	which	there	is	an	already	established	humoral	response	like	to	gluten	in	celiac	disease.60		
From	GALT	to	the	lamina	propria	via	the	blood.	
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Plasmablasts	derived	from	B	cells	activated	in	GALT	can	circulate	via	the	blood	and	home	back	to	the	gut.		Homing	is	mediated	by	a	combination	of	lymphocyte	homing	receptors	for	endothelial	ligands	such	as	a4b7	integrin	receptor	for	mucosal	endothelial	MAdCAM	and	chemokine	receptors	for	chemokines	secreted	by	intestinal	epithelial	cells	such	as	CCR9	and	CCR10	that	facilitate	migration	towards	CCL25	and	CCL28	respectively.61	CCL25	and	CCL28	are	produced	dominantly	by	the	small	intestinal	and	colonic	epithelium	respectively,	thus	providing	a	mechanism	to	bias	homing	of	effector	cells	to	either	small	intestine	or	colon	(Figure	1).		a4b7	and	CCR9	are	inducible	by	retinoic	acid	generated	from	vitamin	A	substrate	by	the	RALDH	enzyme	of	GALT	dendritic	cells.62	Vitamin	D3	metabolite	1,25-Dihydroxyvitamin	D3	may	induce	CCR10	and	thus	guide	migration	of	plasma	cell	precursors	preferentially	to	colon.63	Mucosal	immunisation	with	cholera	toxin,	either	per	oral	or	rectally	generated	circulating	antibody	forming	cells	expressing	the	a4b7	integrin	predominantly.64	Similarly,	antibody-producing	cells	generated	in	response	to	oral	mucosal	immunisation	with	salmonella	vaccine	induced	cells	in	blood	that	migrated	towards	chemokines	CCL25	and	CCL28	(ref	65).		A	molecule	located	in	basement	membrane	surrounding	the	high	endothelial	venules	(HEV)	of	GALT	but	not	HEV	of	peripheral	lymph	nodes	or	tonsils	has	been	identified.		Since	lymphocytes	traffic	through	HEV	is	it	possible	that	this	molecule	could	be	involved	in	selective	recruitment	of	cells	into	intestinal	tissues.66,	67		
	
Relationship	of	B-cell	responses	in	the	gut	to	systemic	humoral	responses	In	steady	state	in	non-immunized	subjects,	80%	of	antibody	secreting	cells	in	peripheral	blood	express	IgA	as	well	as	the	chemokine	receptor	CCR10	and	a4b7	integrin.68	This	suggests	a	dominant	presence	in	blood	of	antibody	secreting	cells	that	originate	from	mucosal	immune	responses	and	also	these	cells	should	be	able	to	return	to	mucosal	sites,	though	they	
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were	also	identified	in	bone	marrow.	Interestingly,	upon	parenteral	tetanus/diphtheria	vaccination,	vaccine	specific	intracellular	IgG	cells	was	observed	in	blood	8	days	after	vaccination,	but	no	similar	surge	of	IgA	plasmablasts	could	be	observed.	This	may	indicate	that	there	is	independent	regulation	of	systemic	and	mucosal	humoral	immune	responses.68	Similarly,	it	was	observed	that	following	anti-CD20	(rituximab)	therapy,	IgA	plasmablasts	were	still	maintained	in	blood	and	plasma	cells	could	be	identified	in	the	gut	lamina	propria	suggesting	that	the	B-cell	precursors	of	these	cells	were	not	affected	by	the	anti-CD20	therapy.69	Of	note,	the	maintenance	of	plasma	cells	in	the	gut	lamina	propria	could	also	be	explained	by	some	gut	plasma	cells	having	long	life	spans	(see	below).		Evidence	for	disconnection	of	mucosal	and	systemic	humoral	responses,	at	least	to	some	degree,	has	also	been	obtained	by	staining	of	B	cells	and	plasma	cells	with	fluorescent	virus-like	particles	of	rotavirus.	In	a	study	of	peripheral	blood	of	healthy	subjects	0.6%	of	the	B	cells	stained	with	rotavirus	VP6	particles,	but	only	about	10%	of	these	cells	carried	the	a4b7	gut	homing	receptor.70	The	rotavirus	specific	B	cells	had	a	bias	in	usage	of	VH	gene	segments	when	compared	with	random	memory	B	cells	or	B	cells	of	gut	homing	phenotype,	particularly	VH1-46	but	also	VH4-31	and	VH4-39.	Among	all	gut	homing	B	cells	there	was	bias	for	VH4	gene	family	usage,	particularly	VH4–39.	Interestingly,	rotavirus	specific	lamina	propria	plasma	cells	isolated	with	the	same	type	of	virus-like	particles	have	a	bias	for	VH4	usage	particularly	VH4-39	(refs	17,	20).	These	results,	though	not	comprehensive,	may	suggest	that	the	VH	usage	of	B	cells	that	later	home	to	and	operate	in	the	gut	as	plasma	cells	is	influenced	by	antigen,	but	possibly	also	by	the	mucosal	priming.		It	has	been	suggested	that	the	marginal	zone	B-cell	subset	that	is	normally	resident	in	spleen	and	that	is	responsible	for	systemic	immune	responses	to	bacterial	polysaccharide	antigens	in	humans	may	develop	in	GALT.71	Human	splenic	marginal	zone	B	cells	(unlike	those	in	mice)	
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have	mutated	IGHV	genes	suggestive	of	previous	antigen	encounter	and	their	origin	remains	enigmatic.72		Consistent	with	a	role	for	the	gut	in	development	of	the	systemic	B-cell	repertoire,	Vossenkamper	et	al	observed	that	immature	transitional	type	2	B	cells	are	present	in	GALT	and	that	they	are	activated	in	this	microenvironment.73	This	study	also	described	that	B	cells	in	most	cases	of	the	systemic	autoimmune	disease	systemic	lupus	erythematosus	that	have	been	reported	to	be	defective	in	mechanisms	that	regulate	peripheral	B	cell	tolerance74	are	compromised	in	their	ability	to	enter	the	gut	through	their	reduced	expression	of	a4b7	integrin.	The	significance	of	this	and	any	possible	link	to	the	development	of	marginal	zone	B	cells	remains	to	be	determined. 
	
Antibody	repertoire	and	reactivity	of	gut	plasma	cells	The	immunoglobulin	repertoire	of	the	human	adult	gut	plasma	cells	is	highly	diverse	with	a	high	degree	of	somatic	mutations.75,	76	The	number	of	somatic	mutations	increases	with	age	suggesting	that	cumulated	antigen	exposure	contributes	to	accumulation	of	mutations	over	time.75,	77	Interestingly,	the	degree	of	mutations	is	as	high	in	plasma	cells	of	the	duodenum	as	of	the	colon	despite	the	fact	that	bacterial	colonization	is	scarce	in	the	proximal	gut.75	Dietary	antigens	are	likely	the	major	drivers	for	upper	small	bowel	humoral	responses.	Thus	to	explain	this	observation,	either	dietary	antigens	give	rise	to	highly	mutated	responses	or	alternatively,	plasma	cells	originating	from	a	B-cell	clone	could	have	wide	distribution	over	the	gut.	Gluten-specific	plasma	cells	in	celiac	disease	have	limited	mutations	of	their	antibody	genes,78	and	with	the	reservation	that	celiac	disease	response	might	not	be	representative	of	antibody	responses	to	dietary	antigens	in	general,	this	lends	some	credence	to	the	latter	explanation.	In	fact	this	notion	of	widespread	dissemination	of	plasma	cells	has	received	experimental	support	from	many,	but	not	all	studies.	Early	work	employing	complementarity	determining	region	(CDR)-3	spectratyping	and	sequence	analysis	suggested	clonal	sharing	between	plasma	cells	in	the	small	bowel	and	colon75	as	well	as	between	multiple	distinct	sites	
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in	the	colon.	79	Recent	work	by	use	of	high	throughput	immunoglobulin	VH	gene	sequencing	demonstrated	substantial	clonal	sharing	between	plasma	cells	of	distinct	duodenal	biopsies	of	celiac	disease	patients,	most	notable	for	transglutaminase	2	specific	cells	but	also	for	non-transglutaminase	2	specific	cells.80	Contrary	to	these	observations,	Yuvaraj	et	al	by	sequence	analysis	of	IgA	VH	genes	of	ileal	biopsies	observed	many	clonally	related	sequences	in	one	biopsy,	but	not	between	different	biopsies.81	The	authors	interpreted	this	finding	to	support	the	notion	of	local	expansion	of	IgA	precursor	cells	in	the	lamina	propria,	and	suggested	that	there	could	be	a	first	wave	of	memory	B	cells	originating	in	the	GCs	that	seed	into	the	lamina	propria	and	that	these	cells	then	expand	locally.	In	a	related	but	distinct	model,	He	et	al	suggested	that	colon	lamina	propria	B	cells	by	the	influence	of	enterocyte	produced	APRIL	in	a	T-cell	independent	manner	can	switch	from	IgM	to	IgA2	and	then	differentiate	locally	to	become	plasma	cells.41	In	vitro	experiments	gave	support	for	this	model.	However,	phenotypic	analysis	of	lamina	propria	B	cells	in	situ	provided	little	support	for	neither	of	these	models.	Boursier	et	al	observed	no	signs	of	local	proliferation	of	CD20+	or	CD19+	cells	in	the	lamina	propria	and	found	no	evidence	of	AID	mRNA	expression	in	lamina	propria	outside	the	organized	gut	associated	lymphoid	tissue;82	the	latter	finding	being	consistent	with	more	recent	observations.80	Thus	it	appears	that	the	majority	of	gut	plasma	cells	are	generated	by	GC	reactions,	giving	CSR	and	somatic	mutations,	and	afterwards	the	plasma	cells	are	seeded	into	the	lamina	propria	in	wide	areas	of	the	gut.		Another	useful	source	of	information	for	understanding	gut	humoral	immunity	is	sequencing	in	large	scale	of	immunoglobulin	heavy	and	light	chain	genes	of	single	plasma	cells	and	testing	of	the	reactivity	of	reconstituted	recombinant	monoclonal	antibodies.	Benkert	et	al	sequenced	IgA	and	IgG	plasma	cells	from	the	terminal	ileum	of	healthy	subjects.16	They	found	that	all	antibodies,	both	IgA	and	IgG,	had	high	numbers	of	somatic	mutations.	Again,	evidence	of	clonal	expansions	was	observed;	about	4%	of	all	IgA	and	12%	of	all	IgG	antibodies	were	
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assigned	to	expanded	clones,	but	clonally	related	B	cells	were	not	shared	between	the	IgA+	and	IgG+	plasma	cell	compartments.	Despite	some	low	level	of	cross-reactivity	with	several	bacterial	species,	and	some	degree	of	polyreactivity	to	self-antigens,	both	IgA	and	IgG	plasma	cells	in	general	expressed	antibodies	that	were	highly	specific.	Specific	reactivity	of	recombinant	antibodies	were	also	observed	by	isolation	of	rotavirus	specific	plasma	cells	from	healthy	subjects17	as	well	as	by	transglutaminase	2	and	gluten	specific	plasma	cells	of	celiac	disease	patients.78,	80	Taken	together	these	results	strongly	indicate	that	gut	plasma	cells	are	generated	in	response	to	specific	antigens,	and	they	do	not	give	support	to	a	concept	of	the	existence	of	scarcely	mutated	antibodies	that	have	a	broad	reactivity,	for	instance	to	commensal	bacteria	in	general.	It	has	been	suggested	that	polyreactivity	so	often	cited	as	a	property	of	IgA	could	be	a	consequence	of	nonspecific	binding	through	carbohydrate	groups.83	This	interesting	field	remains	open	to	further	investigation.	 	Immunoglobulin	heavy	chains	are	expressed	with	either	kappa	or	lambda	light	chains.			Whereas	the	ratio	of	IgK:IgL	for	serum	IgG	is	approximately	1.7:1,	the	figure	for	IgA	is	1.2:1	(ref	84).		As	discussed	above,	a	bias	towards	expression	of	IgL	is	also	seen	in	B	cells	expressing	IgA,	in	particular	memory	cells	lacking	CD27	(ref	34).	It	has	been	suggested	that	a	movement	of	B	cells	from	expression	of	kappa	light	chain	to	lambda	light	chain	could	occur	by	receptor	revision	where	B	cells	outside	the	bone	marrow	re-express	RAG	proteins	that	mediate	secondary	light	chain	gene	rearrangements.	Perhaps	the	best	evidence	for	this	is	the	bias	towards	the	most	3’	J	segments	in	lambda	excision	circle	by-products	of	the	rearrangement	process	isolated	from	IgA	plasma	cells.85	Light	chain	drifting	could	be	a	mechanism	that	diversifies	the	antigen-binding	repertoire	of	intestinal	immunoglobulins	alongside	somatic	hypermutation,	and	could	be	a	particular	feature	of	CD27-	memory	cells	that	may	be	independent	of	cognate	interactions	through	CD40	(ref	34).	
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Persistent	gut	humoral	memory;	long-lived	memory	B	cells	and	plasma	cells		Persistent	humoral	memory	to	gut	pathogens	and	other	gut	antigens	can	be	obtained	by	long-lived	memory	B	cells	replenishing	dying	plasma	cells	or	by	plasma	cells	which	themselves	are	long-lived.	The	possibility	of	long-lived	gut	plasma	cells	was	not	considered	until	recently	as	an	early	study	of	mice	established	the	notion	that	gut	plasma	cells	are	short	lived	with	an	average	turnover	of	a	few	days	with	maximal	life	span	of	a	few	weeks.	Staining	of	rotavirus	specific	plasma	cells	in	healthy	individuals	with	no	obvious	recent	history	of	rotavirus	infection,	however	gave	an	indication	that	there	could	be	longevity	among	gut	plasma	cells.17,	
20	The	fact	that	some	but	not	all	IgA	and	IgM	plasma	cells	survive	in	biopsy	cultures	after	4	weeks	without	signs	of	proliferation	supports	the	concept	that	there	could	be	long-lived	plasma	cells	in	the	gut,	but	also	cells	with	shorter	life	spans.18	Gut	plasma	cells	lack	CD95	and	have	higher	mRNA	expression	levels	of	Bcl-2,	Blimp-1,	IRF-4	and	XBP-1	than	intestinal	memory	B	cells	further	indicating	that	the	gut	harbors	long-lived	plasma	cells.20	Future	studies	are	needed	to	establish	whether	there	are	distinct	populations	of	plasma	cells	with	regards	to	life	spans	and	also	how	long	plasma	cells	survive	in	the	gut.			The	importance	of	memory	B	cells	for	gut	humoral	immunity	has	been	extensively	studied	in	the	mouse	and	recently	some	relevant	human	studies	have	also	appeared.	High	throughput	sequence	analysis	of	immunoglobulin	heavy	chain	genes	of	cells	in	colon	biopsies	from	healthy	human	subjects	obtained	before	the	start	of,	four	days	after	and	46	days	after	cessation	of	antibiotic	treatment	revealed	the	same	repertoire	of	expanded	and	non-expanded	clusters	of	clonally	related	IgA	sequences	in	all	samples.	Backed	up	by	parallel	studies	in	mice	where	memory	B	cells	were	seen	to	circulate	between	inductive	compartments	with	clonal	sharing	of	plasma	cells	in	gut	and	mammary	glands,	this	longitudinal	persistence	of	clonally	related	B	cells	in	the	IgA	repertoire	despite	major	changes	in	the	microbiota	was	taken	to	support	the	notion	of	a	continuous	diversification	of	memory	B	cells	and	this	was	considered	
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a	central	element	in	the	shaping	of	the	gut	humoral	response.77	IgA	plasma	cells	of	duodenal	biopsies	of	celiac	disease	patients	not	reactive	to	transglutaminase	(i.e.	covering	most	of	the	repertoire)	on	average	have	10%	related	sequences	among	IgA	CD27+	peripheral	blood	B	cells	also	pointing	to	clonal	relatedness	between	memory	B	cells	and	gut	plasma	cells.86	Based	on	available	data	it	hence	seems	likely	that	long-lived	B	cell	responses	initiated	in	GCs	do	exist	in	humans,	but	the	relative	contribution	of	long-lived	circulating	memory	B	cells	and	long-lived	plasma	cells	in	the	lamina	propria	to	maintain	a	persistent	gut	humoral	response	awaits	clarification.			
Existence	of	plasma	cell	survival	niches	in	the	intestine	It	is	well	established	that	in	the	bone	marrow	and	in	inflamed	tissues	there	are	plasma	cells	with	very	long	life	spans.	The	maintenance	of	long-lived	plasma	cells	in	the	bone	marrow	is	dependent	on	plasma	cells	settling	into	survival	niches	made	up	of	stromal	cells	and	cytokines	(Reviewed	in	87,	88).	Stromal	cell	expression	of	CD44	and	the	chemokine	CXCL12	(binding	CXCR4	on	plasma	cells)	and	the	cytokines	IL-6,	TNF,	APRIL	and	BAFF	(the	two	latter	binding	BCMA	on	plasma	cells)	are	key	components	of	such	niches.	There	is	competition	for	a	finite	number	survival	niches	and	which	cells	make	it	into	a	niche	is	determined	by	stochastic	processes	and	plasma	cell	intrinsic	factors	–	their	competence	to	compete.	Having	entered	the	niche,	the	plasma	cells	express	high	levels	of	the	transcription	factors	Blimp-1,	XBP-1,	and	IRF-
4.	Mouse	studies	have	suggested	that	eosinophils	producing	APRIL	are	important	for	plasma	cell	survival	in	the	bone	marrow	and	for	maintenance	of	IgA	plasma	cells	in	the	gut,	and	presence	of	plasma	cells	adjacent	to	eosinophils	in	human	intestine	might	suggest	a	similar	role	for	eosinophils	in	man.89		(Figure	4)	Interestingly,	culturing	of	gut	biopsies	without	tissue	disruption	gave	the	highest	antibody	production	and	plasma	cell	survival	indicating	a	role	of	the	tissue	environment	also	for	gut	plasma	cell	longevity.18	In	these	gut	biopsy	cultures,	IL-6	and	APRIL	were	detected	and	blocking	of	the	activity	of	endogenous	APRIL	and	IL-6	with	
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BCMA-Fc	anti-human	IL-6	antibody	negatively	affected	antibody	secretion	suggesting	a	role	for	these	cytokines	in	gut	plasma	cell	survival.	By	immunohistochemistry	and	quantitative	real-time	PCR,	APRIL	expression	in	the	lamina	propria	was	found	in	macrophages,	dendritic	cells	and	neutrophils.23	Scarce	or	no	expression	of	APRIL	was	seen	in	the	areas	of	epithelium	adjacent	to	gut	lumen,	but	APRIL	was	intensely	expressed	by	crypt	epithelial	cells	(Figure	6).	Likewise,	mRNA	for	the	APRIL	receptors	TACI	and	BCMA	was	detected	in	microdissected	lamina	propria	tissue.	By	quantitative	real-time	PCR	of	lamina	propria	tissue	devoid	of	lymphoid	aggregates,	expression	of	APRIL	and	BAFF	was	found	in	both	fetal	and	adult	samples	and	there	was	distinct	expression	of	BCMA	in	adult	samples	and	little	expression	of	BAFF-R	and	TACI	in	both	types	of	samples.24	By	flow	cytometry	analysis	of	celiac	disease	biopsies,	BCMA	was	expressed	on	most	plasma	cells,	whereas	BAFF-R	and	TACI	were	expressed	only	by	a	subgroup	of	cells	and	at	variable	levels.	As	for	IL-6,	this	cytokine	is	produced	by	human	small	intestinal	epithelial	and	smooth	muscle	cell	lines	in	vitro	and	such	cells	could	be	sources	for	IL-6	in	the	intact	intestinal	tissue.90	Immunohistochemical	analysis	suggests	that	CXCL12	is	constitutively	expressed	in	the	intestine	by	enterocytes,	but	not	by	stromal	cells,	and	it	is	up-regulated	upon	inflammation.91	Taken	together	it	thus	appears	that	many	components	of	plasma	cells	survival	niches	as	seen	in	the	bone	marrow	exist	in	the	gut	(Figure	4).	
	
Lessons	from	pathology	and	disease	Insight	into	the	gut	humoral	immune	system	does	not	only	come	from	studies	of	healthy	subjects.	Observations	from	patients	with	celiac	disease	in	particular	have	given	useful	insights.			Celiac	disease	is	characterized	by	highly	disease	specific	IgA	and	IgG	antibodies	to	the	autoantigen	transglutaminase	2	(ref	92)	and	deamidated	gluten	(gliadin)	peptides.93	Anti-
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transglutaminase	antibodies	and	probably	also	anti-deamidated	gluten	antibodies	are	only	produced	in	individuals	who	express	HLA-DQ2	and	/or	HLA-DQ8	upon	gluten	consumption.94	The	levels	of	these	antibodies	in	serum	normalize	within	months	after	start-up	of	the	gluten	free	diet.95	The	lesion	localized	in	the	proximal	small	intestine	is	characterized	by	blunting	of	intestinal	villi	and	tissue	leukocyte	infiltration	with	a	particularly	striking	increase	in	density	of	plasma	cells.96	The	strong	disease	association	with	certain	HLA-DQ	allotypes	and	disease	specific	antibodies	demonstrating	the	same	genetic	restriction	points	to	crosstalk	between	T	cells	and	B	cells	being	involved	in	the	pathogenesis.97	Plasma	cells	specific	for	TG2	and	deamidated	gluten	peptides	can	be	isolated	via	staining	with	labelled	antigen	as	they	express	surface	immunoglobulin.	On	average	10%	of	the	plasma	cells	in	the	active	celiac	disease	lesion	are	transglutaminase	2	specific	with	less	cells	being	specific	for	deamidated	gluten.78,	80,	86	The	number	of	transglutaminase	2	specific	plasma	cells	drops	quickly	after	start-up	of	the	gluten	free	diet,	but	interestingly	they	do	not	disappear	completely.98	There	is	high	degree	of	clonal	sharing	of	transglutaminase	2	specific	plasma	cells	between	distinct	duodenal	biopsies,	up	to	70%	as	assessed	by	high	throughput	sequencing	of	immunoglobulin	VH	genes,	giving	support	to	the	notion	of	wide	seeding	of	plasma	cells	in	the	small	intestine.	Moreover,	there	is	poor	correlation	of	density	of	IgA	transglutaminase	2	specific	plasma	cells	in	the	lesion	and	serum	IgA	anti-transglutaminase	2	antibody	levels,	suggesting	that	serum	antibodies	have	a	main	source	outside	of	the	gut.98	Both	the	transglutaminase	2	and	the	gluten	specific	plasma	cells	have	fewer	mutations	than	other	plasma	cells	in	the	lamina	propria.	The	reason	for	this	is	unknown,	but	may	relate	to	these	being	extrafollicular	responses	or	GC	reactions	of	short	duration.	Access	to	GALT	structures	of	celiac	disease	patients	would	help	to	dissect	this,	but	ethical	aspects	represent	clear	restrictions	on	further	research.		The	common	low	mutation	rate	of	the	responses	to	the	two	antigens	could	relate	to	common	T-cell	help;	gluten	reactive	and	HLA-DQ2/DQ8	restricted	T	cells	could	provide	help	to	both	transglutaminase	2	specific	and	deamidated	gluten	specific	B	cells	via	transglutaminase-gluten	peptide	complexes.99	
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Likewise	B	cells	specific	for	the	two	antigens	could	serve	as	antigen	presenting	cells	for	gluten	reactive	T	cells.	Thus	the	abundance	of	transglutaminase	2	and	deamidated	gluten	specific	plasma	cells	and	the	antibodies	being	good	diagnostic	markers	for	disease	could	be	a	reflection	of	B	cells	playing	an	important	role	as	antigen	presenting	cells	amplifying	the	anti-gluten	T-cell	response	rather	than	the	antibodies	themselves	having	a	pathogenic	role.97			
Outlook	Despite	substantial	insight	into	the	generation,	dissemination	and	regulation	of	the	plasma	cell	population	of	the	human	gut	there	is	still	much	to	be	learned.	Available	evidence	suggests	that	the	repertoire	of	human	gut	IgA	plasma	cells	is	formed	in	response	to	specific	recognition	of	antigens,	but	under	unique	molecular	control.	With	the	arrival	of	high	throughput	technologies	that	allow	for	analysis	of	B-cell	receptor	genes	and	transcriptional	programs	at	the	single	cell	level	even	of	cells	specific	for	given	antigens,	it	is	to	be	expected	that	the	near	future	will	give	interesting	new	knowledge	of	the	human	intestinal	B-cell	system.		This	should	help	us	to	make	more	efficient	mucosal	vaccines	and	to	obtain	a	better	understanding	of	gut	immune	disorders.			 	
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Figure	Legends	
Figure	1.		Immune	responses	in	the	intestine	are	initiated	in	GALT	and	in	gut	regional	lymph	nodes.	Whereas	food	and	ingested	antigens	are	present	in	the	small	bowel,	microbial	antigens	represent	a	major	immune	challenge	in	the	colon.	Antigens	at	both	gut	locations	are	sampled	by	FAE.	Dendritic	cells	in	the	subepithelial	area	are	key	regulators	of	the	fate	of	responding	B	cells.		They	express	the	enzyme	retinaldehyde	dehydrogenase	that	catalyzes	the	production	of	retinoic	acid	that	subsequently	imprints	homing	via	the	induction	of	a4b7	and	CCR9.		They	also	secrete	IGIP	and	APRIL	that	together	with	stromally	derived	TGFb	support	IgA	class	switch	recombination.	Following	clonal	expansion,	hypermutation	and	selection	in	the	germinal	centers	of	Peyer’s	patches	or	regional	lymph	nodes,	plasmablasts	enter	the	blood,	via	the	lymphatic	system.	Plasmablasts	subsequently	home	back	to	the	lamina	propria	where	they	differentiate	into	plasma	cells.	The	chemokines	CCL25	and	CCL28	may	contribute	to	the	differential	homing	of	plasmablasts	primed	in	the	small	intestine	or	colon,	though	how	and	where	the	lymphocyte	receptor	of	CCL28,	CCR10	is	induced	is	not	known.		
Figure	2.	Paraffin	sections	of	GALT	in	human	colon	stained	for	A.	CD20	(brown)	B.	IgD	(brown)	and	C.	CD3	(pink)	and	CD8	(brown).		Nuclei	are	counterstained	blue.	The	GC	is	surrounded	by	a	dashed	circle.	Highly	IgD	expressing	naïve	B	cells	in	B	surround	the	GC,	forming	a	relatively	sparse	mantle	zone.	The	more	extensive	marginal	zone	B	cell	population	extends	between	the	mantle	zone	and	the	FAE.	T	cells	in	GALT	are	mostly	CD4+	cells.	T	follicular	helper	cells	defined	by	their	location	in	the	GC	are	rarely	CD8+	and	are	located	predominantly	in	the	light	zone	(LZ)	of	the	GC	where	they	are	involved	in	repertoire	selection.	T	cells	are	rarely	present	in	the	dark	zone	(DZ).		
Figure	3.	Paraffin	section	of	human	ileum	stained	with	CD20	(brown).	Nuclei	are	counterstained	in	blue.	CD20	expressing	B	cells	are	abundant	in	GALT.		The	lamina	propria	
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adjacent	to	GALT	may	contain	B	cells	that	tend	to	be	large	cells	resembling	plasmablasts	(identified	with	a	box	in	A	and	magnified	in	B).	Distant	lamina	propria	however	contains	few,	if	any,	CD20+	B	cells	(box	C).				
Figure	4.	Illustration	of	factors	that	support	plasma	cells	that	can	bind	antigen	through	their	B	cell	receptor	in	the	lamina	propria	niche.	Stromal	cell	derived	IL-6	may	bind	to	plasma	cell	IL-6	receptor	and	APRIL	produced	by	epithelial	cells,	macrophages	or	eosinophils	may	bind	to	BCMA	on	plasma	cells	to	support	plasma	cell	survival.		CXCL12	may	promote	plasma	cell	retention	and	survival	through	binding	CXCR4.	Plasma	cell	frequencies	in	intestine	may	also	be	regulated	by	T	cells	through	the	presentation	of	cognate	antigen	to	local	T	cell	populations.		
Figure	5.		A.	Paraffin	section	of	GALT	from	ileum	stained	for	APRIL	(brown)	and	AID	(pink).		Nuclei	are	counterstained	with	haematoxylin	(blue).	The	GC	is	identified	with	a	dashed	line.	B.	AID	staining	is	confined	to	the	GC	with	the	exception	of	occasional	large	interfollicular	B	cells	that	have	cytoplasmic	AID.	APRIL	is	produced	adjacent	to	B	cells	expressing	AID	in	the	GC.		C.	APRIL	is	abundant	in	cells	with	dendritic	and	macrophage	morphology	beneath	the	FAE.	D.	An	area	where	the	crypt	epithelium	expressing	APRIL	abuts	the	lymphoid	tissue	is	indicated	with	a	dotted	line.		Areas	magnified	in	B,	C	and	D	are	identified	with	labeled	boxes	in	A..	E.	The	receptors	for	soluble	APRIL	and	BAFF	are	illustrated	schematically	for	reference.		
Figure	6.	Paraffin	sections	of	human	ileum	(A	and	B)	and	colon	(C,	D	and	E)	stained	for	IgA	(A)	and	APRIL	(B,	C,	D	and	E).		IgA	plasma	cells	(arrow	heads)	secrete	IgA	that	is	transported	into	the	gut	lumen	following	binding	to	the	pIgR	on	the	basolateral	surface	of	epithelial	cells.	IgA	in	transit	through	epithelial	cells	is	indicated	with	an	arrow.	In	small	intestine	APRIL,	like	the	pIgR,	is	expressed	mostly	in	by	epithelial	cells	in	the	bases	of	the	crypts.		In	contrast,	in	colon,	APRIL	is	expressed	by	subepithelial	macrophages	(D.		Magnified	area	identified	as	a	box	C	)	
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